Obesity as a risk factor for Covid- 19 mortality: an overview of published meta-analyses

2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 (308-311)

АУТОР(И) / AUTHOR(S): Jasmina Obradovic, Jelena Mladenovic, Vladimir Jurisic

Е-АДРЕСА / E-MAIL: jasmina.obradovic@uni.kg.ac.rs

Download Full Pdf   

DOI: 10.46793/ICCBI23.308O

САЖЕТАК / ABSTRACT:

Obesity and Covid-19 affected the world in the form of pandemics. With this brief review was investigated whether obesity is a risk factor for Covid-19 mortality. The search procedure was performed in the PubMed database with restrictions on meta-analysis (MAs), systematic reviews (SRs), and papers published in the English language. A total of 326 papers were obtained, 11 of which were eligible for analysis according to the aim of this study. The reported odds ratio (OR) range was 1.05-3.76, and the reported hazard ratio (HR) was 2.1, but significant heterogeneity was evidenced by I2 values up to 89.1%. Eight MAs and SRs reported an association between obesity and an increased risk of Covid-19 mortality or severe disease, while two studies found no association. One study reported that the risk of Covid-19 mortality is related to morbid obesity with body mass index (BMI)≥40 kg/m2. Good quality MAs and SRs requires good quality of the included studies, which was a great challenge during the Covid-19 pandemic. 

КЉУЧНЕ РЕЧИ / KEYWORDS:

Obesity, Covid-19, Mortality

ЛИТЕРАТУРА / REFERENCES:

  • M. Blüher., Obesity: global epidemiology and pathogenesis, Nature reviews. Endocrinology, 15 (2019) 288–298.

  • World Health Organization. Obesity and overweight. www.who.int/news-room/fact-sheets/detail/obesity-andoverweight (Accessed on 14 July 2023).

  • L. La Sala, A. E. Pontiroli., Prevention of Diabetes and Cardiovascular Disease in Obesity. International journal of molecular sciences, 21(2020) 8178.

  • M. Smith, R. Honce, S. Schultz-Cherry, Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses. Journal of virology, 94 (2020) e00665-2

  • World Health Organization. Tracking SARS-CoV-2 variants. www.who.int/en/activities/tracking-SARS-CoV-2-variants/ (Accessed: 14 July 2023).

  • R. Pranata, M.A. Lim, E. Yonas, R. Vania, A.A. Lukito, B.B. Siswanto, M. Meyer., Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis, Diabetes & metabolism, 47 (2021) 101178.

  • C.W.S. Hoong, I. Hussain, V.M. Aravamudan, E.E. Phyu, J.H.X. Lin, H. Koh., Obesity is Associated with Poor Covid-19 Outcomes: A Systematic Review and Meta-Analysis, Hormone and metabolic research =Hormon- und Stoffwechselforschung = Hormones et metabolisme 53 (2021) 85-93.

  • J.S.Y. Ho, D.I. Fernando, M.Y. Chan, C.H. Sia., Obesity in COVID-19: A Systematic Review and Meta-analysis, Annals of the Academy of Medicine, Singapore 49 (2020) 996-1008.

  • C.I. Vardavas, A.G. Mathioudakis, K. Nikitara, K. Stamatelopoulos, G. Georgiopoulos, R. Phalkey, J. Leonardi-Bee, E. Fernandez, D. Carnicer-ont, J. Vestbo, J.C. Semenza, C. Deogan, J.E. Suk, P. Kramarz, F. Lamb, P. Penttinen., Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe, European respiratory review : an official journal of the European Respiratory Society, 31(2022) 220098.

  • T. Raeisi, H. Mozaffari, N. Sepehri, M. Darand, B. Razi, N. Garousi, M. Alizadeh, S. Alizadeh., The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis, Eating and weight disorders: EWD, 27 (2022) 893-911.

  • B. Tadayon Najafabadi, D.G. Rayner, K. Shokraee, K. Shokraie, P. Panahi, P. Rastgou, et al., Obesity as an independent risk factor for COVID-19 severity and mortality, Cochrane Database Systematic Reviews, 5 (2023) CD015201.
  • Y. Huang, Y. Lu, Y.M. Huang, M. Wang, W. Ling, Y. Sui, H.L. Zhao., Obesity in patients with COVID-19: a systematic review and meta-analysis, Metabolism, 113 (2020) 154378.
  • S.M.M. Aghili, M. Ebrahimpur, B. Arjmand, Z. Shadman, M. Pejman Sani, M. Qorbani, B. Larijani, M. Payab., Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis, International journal of obesity, 45 (2021) 998-1016.
  • X. Zhao, X. Gang, G. He, Z. Li, Y. Lv, Q. Han, G. Wang., Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis, Frontiers in endocrinology, 11 (2020) 595109.
  • W.H. Ng, T. Tipih, N.A. Makoah, J.G. Vermeulen, D. Goedhals, J.B. Sempa, F.J. Burt, A. Taylor, S. Mahalingam., Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis, mBio, 12(2021) e03647-20.
  • L. Deng, J. Zhang, M. Wang, L. Chen., Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis, Epidemiology and infection, 149 (2021) e144.
  • J.P.T. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman., Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560.
  • J.P.T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M.J. Page, V.A. Welch (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook. (Accessed: 17 July 2023)
  • G. Bennett, E. Young, I. Butler, S. Coe., The impact of lockdown during the COVID-19 outbreak on dietary habits in various population groups: a scoping review, Frontiers in nutrition 8 (2021) 626432.
  • F.M. Silva , J. Lima, P.P. Teixeira, G.B. Grezzana, M. Figueiro, T. Colombo, K. Souto, A.T. Stein,. Risk of bias and certainty of evidence on the association between obesity and mortality in patients with SARS-COV-2: An umbrella review of meta-analyses, Clinical nutrition ESPEN 53 (2023) 13–25.